07:00 , Jun 29, 2015 |  BC Week In Review  |  Company News

IGXBio, Cannabis Science deal

The companies will combine Cannabis’ CS-TATI-1 with IGXBio’s GenePro to treat HIV infection. Cannabis will provide IGXBio with an undisclosed number of Cannabis shares in exchange for using GenePro in combined preclinical studies. CS-TATI-1 is...
08:00 , Mar 4, 2013 |  BC Week In Review  |  Company News

Cannabis Science management update

Cannabis Science Inc. (OTCBB:CBIS), Colorado Springs, Colo.   Business: Cancer, Autoimmune, Infectious   Hired: Richard Ogden as CSO, formerly director of HIV scientific affairs at Pfizer Inc.  ...
07:00 , Jul 13, 2009 |  BC Week In Review  |  Company News

Cannabis Science management update

Cannabis Science Inc. (OTCBB:CBIS), San Francisco, Calif.   Business: Cancer, Autoimmune, Infectious   Hired: Robert Melamede as president and CEO; he replaces Steven Kubby, who will remain a director.  ...
07:00 , Jun 15, 2009 |  BC Week In Review  |  Company News

Cannabis Science management update

Cannabis Science Inc. (OTCBB:CBIS), San Francisco, Calif.   Business: Cancer, Autoimmune, Infectious   Hired: Ray Carr as COO, formerly COO of the SFBC Charlotte unit of SFBC International Inc.  ...
07:00 , Apr 6, 2009 |  BC Week In Review  |  Company News

Cannex, Gulf Onshore deal

Cannex reverse-merged with shell company Gulf Onshore. Cannex shareholders have an undisclosed majority ownership of the newco. Cannex's Steve Kubby retains his title as president and CEO of the newco, which is developing a cannabinoid...